Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
NCT00305747
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
BR-DIM
Sponsor
Barbara Ann Karmanos Cancer Institute
Collaborators
[object Object]